Proton therapy - bridging physics and cancer medicine

By Eirik Malinen, Head of the Department of Radiation Biology, Institute for Cancer Research, Oslo University Hospital and Professor II at the section for Biophysics and Medical Physics, Department of Physics, University of Oslo.

Abstract:

Proton therapy will be a new treatment option for Norwegian cancer patients starting in late 2024. The rationale for using accelerated protons (60-250 MeV) instead of conventional X-rays is the superior ability of protons to deposit a high radiation dose over a narrow range in tissue. Using an energy-modulated beam to cover the extension of the tumor, proton therapy yields a high precision cancer treatment. Running and developing proton therapy requires a close collaboration between physics, biology and oncology. Here, we will look at the technical solutions for proton therapy, discuss some clinical use cases, and show some recent results from ongoing research. Also, the talk will include information about the coming experimental infrastructure at the proton therapy center in Oslo.

Biography:

Eirik Malinen is a physicist with expertise in radiotherapy, medical imaging and radiobiology, and has ongoing clinical and pre-clinical activities in X-ray and proton therapy. He has been a member of the various government-appointed national particle therapy project groups since 2010. He is the scientific lead of the pre-clinical proton therapy core facility at Oslo University Hospital.


Cake and coffee/tea is served from 12.00 to 12.15. The talk starts shortly after.

Published May 9, 2024 5:09 PM - Last modified May 9, 2024 5:09 PM